SATB1 and prostate carcinoma: In the past few years, several studies have shown the function of SATB1 as a prognostic biomarker in various types of cancers, such as breast, colorectal, pancreatic, and prostate cancer and other solid tumors, including gastric cancer [26, 72–76].